Calcium lactate

Generic Medicine Info
Indications and Dosage
Dietary supplement
Adult: 300-600 mg (as elemental Ca) daily in divided doses.
Should be taken with food.
Conditions associated with hypercalcaemia and hypercalciuria.
Special Precautions
Patient with sarcoidosis, history of nephrolithiasis. Renal impairment. Pregnancy.
Adverse Reactions
Gastrointestinal disorders: Constipation, bloating, gas.
IM/Parenteral: C
Drug Interactions
May increase the risk of hypercalcaemia with thiazide diuretics. May enhance the effects of digitalis. Increased absorption with vitamin D. Reduced absorption with corticosteroids. May reduce absorption of bisphosphonates, fluoride, fluoroquinolones and tetracyclines.
Mechanism of Action: Ca lactate is used to treat or prevent negative serum Ca balance. It also helps prevent or reduce the rate of bone loss, moderate nerve and muscle performance, and allow normal cardiac function.
Absorption: Absorbed mainly from the small intestine via active transport and passive diffusion.
Distribution: Crosses the placenta and enters the breast milk. Plasma protein binding: 45%.
Excretion: Primarily via faeces as unabsorbed calcium.
Chemical Structure

Chemical Structure Image
Calcium lactate

Source: National Center for Biotechnology Information. PubChem Database. Calcium lactate, CID=13144, (accessed on June 25, 2020)

Store below 25°C.
MIMS Class
ATC Classification
A12AA05 - calcium lactate ; Belongs to the class of calcium-containing preparations. Used as dietary supplements.
Anon. Calcium lactate. Lexicomp Online. Hudson, Ohio. Wolters Kluwer Clinical Drug Information, Inc. Accessed 08/05/2020.

Anon. Calcium Salts. AHFS Clinical Drug Information [online]. Bethesda, MD. American Society of Health-System Pharmacists, Inc. Accessed 08/05/2020.

Buckingham R (ed). Calcium. Martindale: The Complete Drug Reference [online]. London. Pharmaceutical Press. Accessed 08/05/2020.

Calcium Lactate Tablets BP 300 mg (Accord-UK Ltd). MHRA. Accessed 08/05/2020.

Calcium Lactate Tablets BP 300 mg (Dalkeith Laboratories Ltd). MHRA. Accessed 24/06/2020.

Joint Formulary Committee. Calcium Lactate. British National Formulary [online]. London. BMJ Group and Pharmaceutical Press. Accessed 08/05/2020.

Disclaimer: This information is independently developed by MIMS based on Calcium lactate from various references and is provided for your reference only. Therapeutic uses, prescribing information and product availability may vary between countries. Please refer to MIMS Product Monographs for specific and locally approved prescribing information. Although great effort has been made to ensure content accuracy, MIMS shall not be held responsible or liable for any claims or damages arising from the use or misuse of the information contained herein, its contents or omissions, or otherwise. Copyright © 2024 MIMS. All rights reserved. Powered by
  • Calcium Lactate DHA
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in
Register or sign in to continue
Asia's one-stop resource for medical news, clinical reference and education
Already a member? Sign in